President Trump stood on stage Monday with a man who spent much of 2024 campaigning against him, billionaire Mark Cuban, and declared they share exactly one thing in common. The occasion was not a détente over politics. It was a White House event to announce that 600 generic drugs are being added to the government prescription website TrumpRx.gov, with Cuban's Cost Plus Drugs among the private-sector partners selling directly to consumers.
The scene was striking on its face. Cuban endorsed former Vice President Kamala Harris last year and spent months as one of the most visible surrogates for the Democratic ticket. Now he was laughing alongside Trump at the White House while the president ribbed him for backing the losing side.
Trump did not let the moment pass without comment. Asked about working with a man who had openly opposed him, the president was direct, as the New York Post reported:
"Well, he made a mistake. It was a big mistake."
The crowd laughed. Cuban laughed. And then both men got back to the subject at hand, lowering the cost of prescription drugs for American consumers.
The announcement centers on TrumpRx.gov, the administration's prescription-drug website. Trump said the platform will now incorporate a massive catalog of low-cost generic medications, giving consumers a single destination to find the lowest possible price.
"By incorporating this massive catalog of low-cost generics at TrumpRx.gov, consumers will now have one source to ensure that they're getting the lowest possible cost on their prescription, so they have a real option now."
Three private-sector companies will sell through the site: Cuban's Cost Plus Drugs, Amazon Pharmacy, and GoodRx. The model bypasses the traditional insurance middlemen that have long inflated drug prices. Cost Plus Drugs, which Cuban founded in 2022, sells medications at cost with a 15 percent markup plus a fee covering pharmacy labor and shipping. The company posts exactly how much it paid manufacturers for every medicine it sells, a level of transparency almost unheard of in the pharmaceutical industry.
That transparency is exactly the kind of market-based reform that conservatives have argued for. No new entitlement. No government price-fixing. Just a platform that forces prices into the open and lets consumers shop.
The political optics were impossible to miss. Cuban had not merely voted for Harris, he had been one of her most prominent business-world advocates, appearing on cable news and social media to make the case against Trump. Fox News noted that the partnership was "politically unexpected" given Cuban's role as a vocal Trump critic during the campaign.
Cuban, for his part, tried to keep the focus narrow. Speaking to reporters outside the West Wing on what he described as a 92-degree day, the former Dallas Mavericks owner insisted that his politics were beside the point.
"My politics don't matter to this at all. The goal is to reduce the cost of health care, and we're 100% aligned."
He went further, saying he would work with anyone willing to make health care cheaper. "If you're going to make health care cheaper, you're my new best friend," Cuban told reporters. He described his long relationship with Trump, the two have been friends for more than 20 years, as one of "love-hate."
When pressed on his 2024 endorsement of Harris, Cuban waved it off. "I'm not going to go there; it doesn't matter," he said, calling it "last season." He said that after the election, it was important to work with the president regardless of past disagreements.
The pattern of unlikely figures aligning with this White House keeps repeating. It echoes the way Senator John Fetterman broke with his own party to back Trump's Iran strikes, putting policy results ahead of partisan loyalty.
Trump appeared to enjoy the dynamic. He told Cuban he was "looking good" and framed their shared purpose in plain terms:
"We have the same thing, one thing, in common. We want to make people better and keep them wealthy."
The line drew applause. It also captured something real about the administration's approach to health care costs, frame the issue around consumer savings, recruit private-sector partners who have already proven the model works, and let the results speak louder than the politics.
Cuban said Trump was "playing" when he needled him about backing Harris. Whether that is entirely true or partly wishful thinking, the billionaire clearly decided that showing up at the White House to sell cheaper drugs was worth whatever grief he might take from his friends on the left.
This kind of cross-aisle cooperation has become a recurring feature of Trump's second term. Just weeks ago, two Senate Democrats broke ranks to advance Trump's Federal Reserve nominee Kevin Warsh, another sign that the president's deal-making instincts can pull support from unexpected quarters.
Cuban's Cost Plus Drugs has been a disruptor since its founding in 2022. The company's business model is simple enough that it fits on a napkin: buy generic drugs from manufacturers, mark them up 15 percent, add a flat fee for labor and shipping, and post the wholesale cost for anyone to see.
The result is drug prices that often undercut what insured patients pay through traditional pharmacy benefit managers. The PBM system, the opaque network of middlemen that negotiates drug prices between manufacturers, insurers, and pharmacies, has drawn bipartisan criticism for years. Cost Plus Drugs simply routes around it.
Adding Amazon Pharmacy and GoodRx to the TrumpRx.gov platform expands the competitive pressure further. Consumers who visit the site will be able to compare prices across three vendors, all operating outside the traditional insurance model. For a patient paying out of pocket or stuck with a high-deductible plan, the savings could be substantial.
Trump has shown a willingness to pursue unconventional alliances when they serve his policy goals. His administration has also made headlines for securing the release of five prisoners held in Belarus and Russia, another area where results mattered more than the political pedigree of the partners involved.
Standing outside the West Wing with the White House looming behind him, Cuban fielded one more question that had nothing to do with prescription drugs: Would he run for president?
His answer was two words, minus the niceties: "H*** no."
He added, with a grin: "Too hot." Whether he meant the weather or the political climate, he did not clarify.
The exchange was a reminder that Cuban remains a free agent in American politics, willing to endorse a Democrat one cycle and stand at a Republican president's side the next, so long as the deal on the table suits his interests. That kind of flexibility makes him an unreliable ally for either party. But on Monday, it made him a useful one for an administration eager to show it can deliver lower drug prices without expanding government.
Trump himself has shown a similar willingness to keep his options open when it comes to political partnerships, as seen in his recent public weighing of Vance against Rubio for 2028, a reminder that loyalty in this White House is measured by results, not résumés.
The 600 generic drugs now being added to TrumpRx.gov represent a tangible expansion of the platform. But open questions remain. The announcement did not specify which drugs are included, what the average savings will look like compared to traditional pharmacy prices, or whether additional vendors will join the site in the future.
Cuban framed the effort as nonpartisan. "Democrats want cheaper medications, too," he told reporters. "When all is said and done, the goal is the goal. How do we make medications and healthcare cheaper? That's all I care about."
Fair enough. But the platform is called TrumpRx, it lives on a.gov domain, and the man who built it is the president of the United States. If drug prices drop for millions of Americans because this website works, there will be no confusion about who gets the credit.
When your loudest critic shows up at your house to help sell your product, you are probably doing something right.